FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients

January 2019
Type
Journal article
Publication
British Journal of Cancer, (121), 7, pp. 584-592, https://doi.org/10.1038/s41416-019-0553-z